Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE)

NCT03950622 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1205

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: V114
BIOLOGICAL: Prevnar 13®

Sponsor

Merck Sharp & Dohme LLC